XTNTW

Xtant Medical Holdings, Inc.

 
Warrants SEC Reporting - Current
Pink Current Information
Contact Info
  • 664 Cruiser Lane
  • Belgrade, MT 59714

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0001453593
Fiscal Year End 12/31
OTC Marketplace Pink Current
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: DE, USA
Year of Inc. 2006
Employees 148 a/o Dec 17, 2014
Company Officers/Contacts
Carl O'Connell Interim CEO
Darrel Holmes COO
John Gandolfo CFO
David Kirschman EVP, CSO
Jill Gilpin General Counsel
Company Directors
Kent Swanson Chairman
John Deedrick
David Goodman
David Kirschman
Michael Lopach
Jon Wickwire
Service Providers
Accounting/Auditing Firm
EKS&H
7979 E. Tufts Ave.
Suite 400
Denver, CO, 80237
United States
 
Securities Counsel

Not Available
Investor Relations Firm
Cockrell Group
1230 Peachtree Street
19th Floor
Atlanta, GA, 30309
United States
 
Company History
  • Formerly=Bacterin International Holdings, Inc. until 8-2015
  • Formerly=K-Kitz, Inc. until 7-2010
XTNTW Security Details Other Company Securities
Share Structure
Market Value1 Not Available
Authorized Shares Not Available
Outstanding Shares Not Available
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Transfer Agent(s)
Shareholders
Shareholders of Record Not Available
Short Selling Data
Short Interest 84 (1.2%)
Mar 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security